Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies
Liu X , Chen F, Liu L, Zhang Q
BMC Endocr Disord. 2023;23(1):1.
Leggi
Breaking news
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use
Rossing P, Agarwal R, Anker AS, et al.
Diabetes Obes Metab. 2023;25(2):407-16.
Leggi
Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study
Otsubo N, Fukuda T, Beppu H, et al,
BMC Endocr Disord. 2023;23(1):5.
Leggi
The relationship between percent time less than 70 mg/dl and percent time less than 54 mg/dl measured by continuous glucose monitoring
Beck RW, Raghinaru D, Calhoun P, Bergenstal MR
Diabetes Technol Ther. Pub. online 28 Dec 2022.
Leggi
Lipoprotein(a) in youth and prediction of major cardiovascular outcomes in adulthood
Raitakari O, Kartiosuo N, Pahkala K, et al.
Circulation. 2023;147(1):23-31.
Leggi
Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial
Yamaguchi S, Shimabukuro M, Tanaka A, et al.
Diabetes Obes Metab. 2023;25(2):354-64.
Leggi
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes
Moody AJ, Molina-Wilkins M, Clarke GD, et al.
Diabetes Obes Metab. 2023;25(2):426-34.
Leggi
Standards of Medical Care in Diabetes – 2023
American Diabetes Association
Diabetes Care. 2023;46(Supplement_1):S1-S284.
Leggi
Once-weekly semaglutide in adolescents with obesity
Weghuber D, Barrett T, Barrientos-Pérez M, et al.
N Engl J Med. 2022;387:2245-2257.
Leggi
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial
Lee YJ, Cho JY, You SC, et al.
European Heart Journal. ehac709.
Leggi